Clinical Trials Browser

Uterine Cervical Neoplasms, Vaginal Neoplasms

Carcinosarcoma

Locally Advanced Cervical Adenocarcinoma

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Uterine Cervical Neoplasms

Prostatic Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Pancreatic Neoplasms

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Uterine Cervical Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Uterine Cervical Neoplasms

Pancreatic Neoplasms

Uterine Cervical Neoplasms

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Uterine Cervical Neoplasms

Anemia, Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Uveal Melanoma, Choroid Neoplasms, Uveitis

Clinical Trials

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

A Study of Patients Receiving High-Dose Rate Brachytherapy

Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer

Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Radiation Therapy in Treating Patients With Cervical Cancer

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Collaborative Ocular Melanoma Study (COMS)